| Name | Title | Contact Details |
|---|
At Inipharm, we`re building on novel insights and applying our chemistry expertise to develop therapies for patients with liver disease. Inipharm`s lead program is focused on small-molecules to target the activity of HSD17B13, a highly validated, genetically defined target for multiple severe liver and related diseases.
Uromedica is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our mission is to create tools that empower physicians and consumers by increasing their access to actionable data.
Curie Co is replacing chemicals with clean, sustainable proteins and enzymes.